CUNY SPH faculty join group of experts in releasing consensus statement on non-alcoholic fatty liver disease

Nov. 3, 2021
Macrovesicular hepatic steatosis of the liver (fatty liver disease)

Non-alcoholic fatty liver disease (NAFLD) is a potentially serious multisystem disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with a wide range of social and economic implications. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community.

In a global Delphi study, a multidisciplinary group of experts including CUNY SPH Senior Scholar Jeffrey Lazarus, Professor Terry Huang, and Associate Professor Diana Romero developed and endorsed a set of consensus statements and recommendations that provide needed guidance for the creation and implementation of health system and public health responses that will rise to this challenge. The statement was published last week in Nature Reviews.

“The strength of this statement is two-fold,’ stated Dr Romero, methodologist for the Delphi study. “It represents almost 100 percent consensus by over 200 experts from around the world which resulted in recommendations on a broad range of topics—from epidemiology, awareness, care, and treatment to public health policies and leadership.” It is hoped that this will provide a strong foundation for a comprehensive response to NAFLD that includes the public health community.

scrollToTop